SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +73.6% | +26.5% | -38.6% | +0.0% | -10.7% | +41.8% | +18.5% | -54.7% | +100.8% | -9.3% | -34.7% | +0.0% | -87.4% | +1,986.8% | +9.2% | +6.7% | +100.0% | -53.1% | +242.5% | -55.9% | +58.8% | -28.2% | -32.2% | +0.0% | +75.2% | +0.5% | -76.1% | +0.0% | +240.0% | +120.6% | +183.6% | +0.0% | +3,253.5% | -23.6% | -85.6% | -76.9% | +499.7% | -91.7% | +119.3% | |
| – | +29.0% | +93.6% | -56.1% | +0.0% | -7.7% | +64.8% | +4.4% | -55.6% | +42.2% | +69.0% | -16.6% | +0.0% | -19.2% | +52.7% | +45.9% | -53.5% | +100.0% | +7.6% | +50.2% | -77.7% | +278.0% | -55.9% | -18.8% | +0.0% | +61.2% | +69.8% | -80.9% | +0.0% | +281.7% | +86.7% | +208.4% | +0.0% | +1,351.5% | -30.3% | -42.3% | +69.1% | +203.1% | -85.5% | – | |
| – | +92.5% | +7.4% | -29.7% | +0.0% | -11.7% | +34.1% | +24.3% | -54.4% | +120.4% | -26.3% | -43.6% | +0.0% | -137.3% | – | +0.0% | +28.4% | +100.0% | -61.1% | +312.0% | -53.1% | +45.0% | -23.7% | -33.5% | +0.0% | +76.8% | -6.8% | -75.2% | +0.0% | +233.8% | +126.4% | +180.2% | +0.0% | +3,545.0% | -23.2% | -88.0% | -115.6% | – | -112.7% | – | |
| – | +10.5% | -0.4% | -16.3% | +0.0% | +91.8% | -22.1% | +38.4% | -37.6% | +0.7% | +0.1% | -6.5% | +0.0% | +34.3% | +51.7% | -15.1% | +22.6% | +100.0% | -59.2% | +227.2% | -64.2% | +40.4% | -20.3% | -4.3% | +0.0% | +41.3% | -10.9% | +0.6% | +0.0% | +153.9% | +79.5% | -89.7% | +0.0% | +1,926.0% | +87.6% | +82.3% | +39.8% | +54.8% | -62.1% | +28.0% | |
| – | +33.4% | +27.3% | -44.2% | +53.3% | +24.1% | -6.0% | -17.7% | -27.5% | +36.8% | +12.8% | +7.6% | -42.2% | +33.0% | +48.8% | +22.1% | +17.8% | +150.7% | +3,612.0% | -96.3% | -59.4% | +76.4% | -36.9% | +137.9% | -65.4% | +31.0% | +12.6% | -4.5% | -49.6% | +85.5% | +53.7% | +75.8% | – | – | – | – | – | – | – | – | |
| – | +23.4% | +1.4% | -16.7% | +0.0% | +24.1% | -6.0% | +16.6% | -32.2% | +23.0% | +14.3% | -35.8% | +0.0% | +41.1% | +46.8% | -21.9% | +106.7% | +71.2% | -71.8% | +382.7% | -52.8% | +71.6% | -35.2% | -15.5% | +0.0% | +32.7% | +8.6% | -44.5% | +0.0% | +102.1% | +63.7% | +18.1% | +0.0% | +148.6% | +146.8% | -36.0% | +172.3% | +15.1% | -64.2% | -3.2% | |
| – | – | +39.1% | -48.8% | -60.2% | -582.0% | – | +116.1% | -204.1% | – | -130.6% | – | – | – | – | +64.7% | -34.2% | +99.9% | -24.0% | +222.1% | -53.6% | -7.4% | +18.3% | -69.7% | +0.0% | +324.9% | -34.6% | -164.1% | – | – | – | +609.3% | +0.0% | +5,045.9% | -26.8% | -91.7% | -274.8% | – | – | – | |
| – | +16.1% | -4.5% | +2.0% | +0.0% | +10.9% | +8.8% | +1.7% | -36.1% | -28.4% | +17.1% | -22.3% | +0.0% | +4.7% | -12.2% | +68.5% | -30.7% | +100.0% | -27.9% | +26.0% | -50.7% | -23.4% | -9.9% | -29.9% | +0.0% | -6.7% | -11.4% | +50.3% | +0.0% | +68.8% | +42.4% | -38.2% | +0.0% | +364.0% | -13.7% | -52.6% | +2.9% | +289.4% | -89.4% | +656.1% | |
| – | – | +53.6% | -73.3% | +0.0% | -473.9% | – | +423.6% | -176.1% | – | -137.0% | – | – | – | – | +61.6% | -31.6% | +100.0% | -26.9% | +241.4% | -53.2% | -6.3% | +18.7% | -69.1% | +0.0% | +317.9% | -32.5% | -158.1% | – | – | – | +639.8% | +0.0% | +3,266.6% | -26.7% | -87.3% | -191.8% | – | – | – | |
| – | +100.0% | +1,800.0% | +356.6% | +0.0% | -78.1% | +451.3% | +47.0% | -10.6% | -20.1% | -39.3% | -119.5% | – | – | – | +68.6% | -156.7% | – | – | +333.1% | -74.7% | +29.9% | -6.1% | -55.1% | +0.0% | +186.0% | -36.1% | -137.1% | – | – | +383.9% | +353.3% | +0.0% | +6,017.0% | -2.3% | -91.1% | -246.3% | – | – | – | |
| – | – | +75.1% | -80.9% | -99.1% | -56,300.0% | – | +1,365.2% | -272.6% | – | -170.4% | – | – | -830.3% | – | +38.8% | +22.0% | +100.0% | -59.0% | +236.1% | -44.1% | -31.5% | +54.8% | -59.4% | -50.3% | +579.2% | -35.9% | -195.0% | – | – | – | +1,447.4% | -37.0% | +4,593.9% | -34.2% | -85.6% | -176.5% | – | – | -790.6% | |
| – | – | +19.2% | -20.6% | +0.0% | -103.4% | – | +159.4% | -99.0% | +10,420.0% | -91.7% | -45.2% | -36.7% | -6,749.7% | – | +17.2% | – | – | -28.1% | +215.9% | -51.8% | -6.3% | +16.9% | -64.7% | -0.4% | +255.5% | -30.5% | -146.5% | – | – | +1,367.0% | +622.7% | -0.1% | +4,980.4% | -26.4% | -90.7% | -218.3% | – | – | -229.0% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.